Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from carbamazepine to lacosamide adjunctive to levetiracetam in men with partial-onset seizures
2010-022534-84Phase 3Terminated
- Sponsor
- UCB
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lacosamide in epilepsy and Focal onset seizure, sponsored by UCB. Primary endpoint: Change in serum SHBG concentration. Started Feb 2011; status: terminated.
02
Drugs
lacosamide
03
Conditions
epilepsyFocal onset seizure
Beyond the preview
Go deeper on 2010-022534-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022534-84.